Actively Recruiting
Effectiveness of Kinesio Taping in Patients With Chronic Breast and/or Truncal Oedema After Treatment for Breast Cancer.
Led by Universiteit Antwerpen · Updated on 2025-09-03
128
Participants Needed
4
Research Sites
170 weeks
Total Duration
On this page
Sponsors
U
Universiteit Antwerpen
Lead Sponsor
U
University Ghent
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of the KiTaLymph trial is to investigate whether the application of kinesio tape is effective in women with persistent (\>6 months) breast and/or truncal oedema after treatment for breast cancer. The main objectives are to assess whether kinesio taping: * reduces pain and symptoms, * decreases swelling, * improves quality of life (QoL). This study will compare a control group receiving standard care, decongestive lymphatic therapy (DLT), to an intervention group receiving DLT in combination with kinesio taping, in order to determine whether the addition of kinesio tape yields superior clinical outcomes. Participants will be randomly allocated to one of the two study arms. Both groups will participate in a 4-week intervention phase, consisting of two treatment sessions per week. This will be followed by a 6-month follow-up period to assess the durability of treatment effects and cost-related outcomes. A total of approximately 128 participants will be recruited. Outcome assessments will be conducted at baseline, immediately post-intervention (1 month), and at 3 and 6 months following the end of the intervention. These assessments will include standardised patient-reported outcome measures evaluating symptoms, quality of life, and pain, namely, the Breast Edema Questionnaire (BrEQ), the EORTC-QLQ-BR23, the EQ-5D-5L, and a visual analogue scale (VAS), as well as objective physical measurements of oedema using the LymphScanner (expressed as percentage water content, PWC). In addition to the primary research objective, several sub-studies will be conducted. These will include: (1) a longitudinal analysis of the effects of standard treatment; (2) an evaluation of the responsiveness and clinical utility of the BrEQ; and (3) a cross-sectional analysis of the compression pressure exerted by various compression bras. All sub-studies are methodologically feasible within the projected sample size of the primary objective and aim to provide supplementary insights into the clinical management of breast and truncal oedema.
CONDITIONS
Official Title
Effectiveness of Kinesio Taping in Patients With Chronic Breast and/or Truncal Oedema After Treatment for Breast Cancer.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female patients previously treated for breast cancer.
- Persistent breast and/or truncal oedema lasting more than 6 months, established at least six months after completing radiotherapy.
- Breast Edema Questionnaire (BrEQ) score of 9 or higher.
- LymphScanner physical water content (PWC) measurements showing at least one of the following: truncal oedema ratio 1.32 or higher; breast oedema ratio 1.28 or higher; local PWC of 52.90%.
- At least one clinical sign of breast and/or truncal oedema, such as visible swelling compared to the other side, bra imprint on the skin, or peau d'orange appearance on the breast.
You will not qualify if you...
- Skin infections or wounds on the breast or trunk that prevent applying kinesio tape.
- Age under 18 years.
- Unable to read and understand Dutch.
- History of mastectomy.
- Metastatic breast cancer.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
University of Antwerp
Antwerp, Belgium, 2000
Actively Recruiting
2
Iridium Network
Antwerp, Belgium, 2610
Actively Recruiting
3
Ghent University Hospital
Ghent, Belgium, 9000
Actively Recruiting
4
AZ Groeninge
Kortrijk, Belgium, 8500
Actively Recruiting
Research Team
T
Tessa De Vrieze, Phd pt postdoctoral fellow
CONTACT
N
Nick Gebruers, Associate Professor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here